Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,124.55 -14.71 -0.47%
FTSE 100 6,577.05 -7.12 -0.11%
DAX 9,298.71 -19.11 -0.21%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Patriot Wins Patent Infringement Suit Against HTC Corporation



        Patriot Wins Patent Infringement Suit Against HTC Corporation

PR Newswire

CARLSBAD, Calif., Oct. 3, 2013

CARLSBAD, Calif., Oct. 3, 2013 /PRNewswire/ -- Patriot Scientific Corporation
(OTC: PTSC) announced today that it has won its patent infringement lawsuit
against HTC Corporation.  In litigation before the United States District
Court for the Northern District of California, HTC was found to infringe
multiple claims within Patriot's US 5,809,336 patent.  The '336 patent is one
of several patents that are part of a larger portfolio held by Patriot, known
as the Moore Microprocessor Patent (MMP) Portfolio™. 

"This represents an extraordinary victory and vindication for the '336 patent
and sends a strong signal to the marketplace that infringers of the MMP
portfolio will be held accountable for their actions," stated Cliff Flowers,
Patriot's Interim Chief Executive Officer.  "In addition to our victory over
HTC in U.S. District Court, the MMP portfolio has survived 17 re-examination
challenges before the USPTO.  The MMP portfolio has near universal
applicability in microprocessor design and companies utilizing this technology
should take note of our successes at the USPTO and in court."

"We are gratified that the jury correctly decided that HTC's accused products
infringe the '336 patent," stated lead trial attorney Jim Otteson of Agility
IP Law, LLP.  "We know that microprocessor technology can be daunting for lay
people to understand, but the jury obviously worked hard to come to the right
decision.  And we also know that many other companies' products (and many
other HTC products not at issue in this case) work the same way as HTC's
infringing products.  So that should give everyone something to think about."

Patriot's win against HTC comes after a protracted legal battle that was
initiated in 2008.  There are additional proceedings in U.S. District Court,
currently stayed, alleging infringement of the '749, '890 and '336 patents
against Barnes & Noble Inc., Garmin Ltd., Huawei Technologies Co. Ltd., LG
Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co.
Ltd., and ZTE Corporation.

"On behalf of Patriot's Board I wish to give recognition to our legal teams
and express our thanks for their extraordinary efforts and competence.  Most
importantly, however, we wish to express our gratitude for the perseverance of
our long-standing shareholders who have patiently waited for this day.  While
there will certainly be additional obstacles to confront and overcome, we look
forward to this win as a step towards fulfilling our plans to increase
Patriot's value and facilitating opportunities to return consideration to our
shareholders," added Mr. Flowers.

About Patriot Scientific Corporation

Headquartered in Carlsbad, California, Patriot Scientific Corporation is the
co-owner of the Moore Microprocessor Patent Portfolio™. For more information
on PTSC, visit www.ptsc.com. 

About the MMP Portfolio™

The MMP Portfolio includes US patents as well as their European and Japanese
counterparts, which cover techniques that enable higher performance and lower
cost designs essential to consumer and commercial digital systems ranging from
PCs, cell phones and portable music players to communications infrastructure,
medical equipment and automobiles.

Safe Harbor Statement: Statements herein which are not purely historical,
including statements regarding Patriot Scientific Corporation's intentions,
hopes, beliefs, expectations, representations, projections, plans or
predictions of the future are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. The forward-looking
statements involve risks and uncertainties including, but not limited to, the
risk that the recently filed actions and litigation strategy may not be
successful and the risks and uncertainties relating to the future of our MMP
joint-venture.  It is important to note that the company's actual results
could differ materially from those in any such forward-looking statements.
Factors that could cause actual results to differ materially include, but are
not limited to, risks and uncertainties associated with the effect of changing
economic conditions, trends in the products markets, variations in the
company's cash flow, market acceptance risks, patent litigation, technical
development risks, and seasonality.  Our business could be affected by a
number of other factors, including the risk factors listed from time to time
in the company's SEC reports including, but not limited to, the annual report
on Form 10-K for the year ended May 31, 2013. The company cautions investors
not to place undue reliance on the forward-looking statements contained
herein. Patriot Scientific Corporation disclaims any obligation, and does not
undertake to update or revise any forward-looking statements made herein.

Contact:
Patriot Investor Relations
ir@ptsc.com
760-547-2700

SOURCE Patriot Scientific Corporation

Website: http://www.ptsc.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement